TIAA CREF INVESTMENT MANAGEMENT LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 211 filers reported holding BLUEBIRD BIO INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2019$29,299,000
+29.0%
186,226
-18.7%
0.02%
+16.7%
Q4 2018$22,718,000
-68.8%
229,011
-54.0%
0.02%
-25.0%
Q3 2018$72,712,000
+84.3%
498,032
+98.1%
0.02%
-11.1%
Q2 2018$39,462,000
-0.9%
251,430
+7.8%
0.03%0.0%
Q1 2018$39,824,000
-7.1%
233,230
-3.1%
0.03%
-3.6%
Q4 2017$42,889,000
+35.9%
240,813
+4.8%
0.03%
+27.3%
Q3 2017$31,555,000
+38.9%
229,742
+6.3%
0.02%
+37.5%
Q2 2017$22,714,000
+82.9%
216,219
+58.2%
0.02%
+77.8%
Q1 2017$12,420,000
+36.0%
136,632
-7.7%
0.01%
+28.6%
Q4 2016$9,134,000
+5.7%
148,033
+16.1%
0.01%
+40.0%
Q3 2016$8,639,000
+32.0%
127,462
-15.7%
0.01%0.0%
Q2 2016$6,546,000
-54.6%
151,224
-55.4%
0.01%
-54.5%
Q1 2016$14,426,000
+54.9%
339,424
+134.0%
0.01%
+57.1%
Q4 2015$9,316,000
-26.5%
145,057
-2.1%
0.01%
-30.0%
Q3 2015$12,674,000
-49.6%
148,146
-0.7%
0.01%
-44.4%
Q2 2015$25,129,000
+32.6%
149,249
-4.9%
0.02%
+38.5%
Q1 2015$18,952,000
+72.9%
156,924
+31.3%
0.01%
+62.5%
Q4 2014$10,960,000
+152.9%
119,495
-1.0%
0.01%
+166.7%
Q3 2014$4,333,000
+7.4%
120,759
+15.4%
0.00%0.0%
Q2 2014$4,034,000
+452.6%
104,601
+225.8%
0.00%
+200.0%
Q1 2014$730,000
+46.3%
32,108
+34.9%
0.00%
Q4 2013$499,000
+12.1%
23,801
+44.2%
0.00%
Q3 2013$445,00016,5010.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2016
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders